Nutraceutical Support in Heart Failure: a Position Paper of the International Lipid Expert Panel (ILEP)
Nutrition Research Reviews (2020), 33, 155–179 doi:10.1017/S0954422420000049 © The Author(s) 2020. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:// creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. Nutraceutical support in heart failure: a position paper of the International Lipid Expert Panel (ILEP) Arrigo F. G. Cicero1*, Alessandro Colletti2, Stephan von Haehling3, Dragos Vinereanu4, Agata Bielecka-Dabrowa5, Amirhossein Sahebkar6,7,8, Peter P. Toth9, Željko Reiner10, Nathan D. Wong11, Dimitri P. Mikhailidis12, Claudio Ferri13 and Maciej Banach14,15,16* on behalf of the International Lipid Expert Panel† 1Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy 2Department of Science and Drug Technology, University of Turin, Turin, Italy 3Department of Cardiology and Pneumology, University of Goettingen Medical Center, Goettingen, Germany; German Center for Cardiovascular Disorders (DZHK), partner site Goettingen, Germany 4University of Medicine and Pharmacy Carol Davila, University and Emergency Hospital, Bucharest, Romania 5Department of Cardiology and Congenital Diseases of Adults, Polish Mother’s Memorial Hospital Research Institute (PMMHRI), Lodz, Poland 6Halal Research Center of IRI, FDA, Tehran, Iran 7Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran 8Neurogenic
[Show full text]